Francesco Rubertis Overview

  • Investor Type
  • Angel

  • Investments
  • 2

  • Portfolio
  • 1

  • Exits
  • 1


Francesco Rubertis General Information


Dr. Francesco Rubertis is an Angel Investor. Dr. Rubertis was a Board Member at Sequenta. rancesco is a partner at Index Ventures in the firm's life sciences practice. He joined Index in 1998 and has served on the board of numerous companies including Genmab, Bioxell, Addex, Parallele, 7TM and Pangenetics. Prior to joining Index, Francesco was involved in post-doctoral research in genetics at the Whitehead Institute, Massachusetts Institute of Technology (MIT). He is also the author of several publications in international scientific journals. Francesco has a BA in Genetics and Microbiology from the University of Pavia and a PhD in Molecular Biology from the University of Geneva. He is also a CFA charter holder.

Contact Information

Primary Investor Type
Angel (individual)

Francesco Rubertis Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Velada 04-Oct-2022 Angel (individual) 00000 Other Restaurants, Hotels and Leisure Startup 000000000 00000000 00.0
0000 000 0000 03-May-2013 0000 00000 00000 Information Services (B2C) Bankruptcy: Liquidation

Francesco Rubertis Exits (1)

Company Name Exit Date Exit Type Exit Size
0000 000 0000 01-Jul-2016 0000000000: 000000

Francesco Rubertis Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Francesco Rubertis Team (1)

Name Title Deals Funds Boards Office
Francesco Rubertis Ph.D Angel Investor 0